Results 191 to 200 of about 8,737,377 (294)
Natural Phenolic Antioxidants from <i>Micromeria aybalae</i>: Solvent-Dependent Composition and Bioactivity. [PDF]
Karakus Z, Sarikurkcu C.
europepmc +1 more source
The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad +2 more
wiley +1 more source
Targeting health-related quality of life issues not found with functional outcome measures a year after aneurysm subarachnoid hemorrhage in a Swedish national cohort. [PDF]
Aineskog H +10 more
europepmc +1 more source
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
Systematic screen of RNA binding proteins that enhance circular RNA translation. [PDF]
Lu QY +6 more
europepmc +1 more source
[Letters written] For the Independent Chronicle // Political Maxims, &c. // Prizes in Charlestown Lottery // Proceedings of the Federal Congress, in the House of Representatives of the United ...
Independent Chronicle
core
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both +7 more
wiley +1 more source
Paraplegia Following Decompression Sickness (Caisson Disease): A Journey to Near-Complete Recovery. [PDF]
Michel M L +5 more
europepmc +1 more source
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira +7 more
wiley +1 more source
Changes in Functional and Health-Related Outcomes After a Disability-Delay Program Among Community-Dwelling Older Adults. [PDF]
Chen YC +4 more
europepmc +1 more source

